from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Brief amici curiae of Professor Christopher M. Turoski and The National Association of Patent Practitioners filed.
Response Requested. (Due March 18, 2024)
Brief amici curiae of American Council of the Blind, Blinded Veterans Association, and PRISMS filed.
Brief amici curiae of Salix Pharmaceuticals, Inc. and Ocular Therapeutix, Inc. filed. (Distributed)
Waiver of right of respondents Apotex Inc. and Apotex Corp. to respond filed.
Waiver of right of respondent Teva Pharmaceuticals USA, Inc. to respond filed.
Petition for a writ of certiorari filed. (Response due February 16, 2024)
Application (23A344) granted by The Chief Justice extending the time to file until January 12, 2024.
Application (23A344) to extend the time to file a petition for a writ of certiorari from November 14, 2023 to January 12, 2024, submitted to The Chief Justice.
Vanda Pharmaceuticals Inc., Petitioner, represented by Paul Whitfield Hughes
Apotex Inc. and Apotex Corp., Respondent, represented by Aaron Scott Lukas
Teva Pharmaceuticals USA, Inc., Respondent, represented by John Christopher Rozendaal
American Council of the Blind, Blinded Veterans Association, and PRISMS, Amicus Curiae, represented by Mark Simon Davies
Professor Christopher M. Turoski and The National Association of Patent Practitioners, Amicus Curiae, represented by Ryan C. Morris
Salix Pharmaceuticals, Inc. and Ocular Therapeutix, Inc., Amicus Curiae, represented by Justin James Hasford